Exercise-based Cardiac Rehabilitation After Thoracoscopic Ablation in Patients With Persisent Atrial Fibrillation

Sponsor

Samsung Medical Center (Other)

Overall Status

Completed

CT.gov ID

NCT04500184

Collaborator

(none)

Enrollment

Location

Actual Duration (Months)

0.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Thoracoscopic ablation is a promising treatment of persistent atrial fibrillation. However, the postoperative rehabilitation is very important to prevent early recurrence of atrial arrhythmia. The purpose of this study is to evaluate the efficacy of professional cardiac rehabilitation in patients after thoracoscopic ablation.

Condition or Disease	Intervention/Treatment	Phase
Atrial Fibrillation, Persistent Cardiac Rehabilitation Cardiopulmonary Fitness	Other: cardiac rehabilitation

Study Design

Study Type:

Observational

Actual Enrollment :

24 participants

Observational Model:

Case-Control

Time Perspective:

Retrospective

Official Title:

Can Exercise-based Cardiac Rehabilitation Increase Physical Activity in Patients Who Undergoing Totally Thoracoscopic Ablation?

Actual Study Start Date :

Jun 1, 2017

Actual Primary Completion Date :

May 30, 2018

Actual Study Completion Date :

May 31, 2020

Arms and Interventions

Arm	Intervention/Treatment
Exercise group patients who underwent cardiac rehabilitation	Other: cardiac rehabilitation rehabilitation performed by professional trainers
Control group patients who did not undergo cardiac rehabilitation

Arm

Intervention/Treatment

Exercise group

patients who underwent cardiac rehabilitation

Other: cardiac rehabilitation

rehabilitation performed by professional trainers

Control group

patients who did not undergo cardiac rehabilitation

Outcome Measures

Primary Outcome Measures

Recurrence of atrial fibrillation [every 6 months for 1 year]
Atrial fibrillation recurrence after surgical treatment
functional recovery [6 months after intervention]
exercise capacity and international physical activity questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 80 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

patients who underwent thoracoscopic ablation due to persisent atrial fibrillation

Exclusion Criteria:

below 18 years
over 80 years old
malignancy
pregnancy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Samsung Medical Center	Seoul		Korea, Republic of	135-710

Sponsors and Collaborators

Samsung Medical Center

Investigators

Principal Investigator: Dong Seop Jeong, PhD, Samsung Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Dong Seop Jeong, Clinical professor, Samsung Medical Center

ClinicalTrials.gov Identifier:

NCT04500184

Other Study ID Numbers:

samsungmc_rehab_TTA

First Posted:

Aug 5, 2020

Last Update Posted:

Aug 5, 2020

Last Verified:

Jul 1, 2020

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Atrial Fibrillation

Study Results

No Results Posted as of Aug 5, 2020